文献速递关节外科

并非所有非骨水泥股骨柄都相同,但结果可能相当

Not all cementless femoral stems are created equal but the results may be comparable.
PubMed 文献 · Bone Joint J · 2017-01-01

该研究比较了三种不同设计的非骨水泥股骨柄在初次全髋关节置换术后十年的生存率和影像学结果,纳入了三个前瞻性连续队列(每组约100髋)。以无菌性松动为终点,三种股骨柄的十年生存率为97%至100%,表现出优异的生存率。

要点

  • 队列1使用PCA柄,因任何原因翻修生存率91%,无菌性松动终点生存率97%。
  • 队列2使用Prodigy柄,因任何原因翻修生存率88%,无菌性松动终点生存率100%。
  • 队列3使用Summit柄,因任何原因翻修生存率95%,无菌性松动终点生存率100%。

核心结论

  • 以股骨假体无菌性松动翻修为终点,三种设计理念不同的股骨假体在十年时均表现出优异的生存率,范围为97%至100%。

研究设计与样本

  • 研究为比较三种前瞻性连续队列的生存率和影像学结果,随访至十年。
  • 队列1:91例连续患者(100髋)在1983年10月至1986年1月期间接受PCA非骨水泥股骨柄全髋关节置换术。
  • 队列2:86例连续患者(100髋)在1994年6月至1997年10月期间接受Prodigy广泛多孔涂层非骨水泥股骨柄全髋关节置换术。
  • 队列3:88例连续患者(100髋)在2002年4月至2003年10月期间接受Summit近端多孔涂层三锥度非骨水泥股骨柄全髋关节置换术。
  • 所有三组均接受前瞻性临床和影像学评估。

主要发现

  • 队列1的Kaplan-Meier生存率:以任何原因翻修为终点为91%(95%CI 88至94),以无菌性松动为终点为97%(95%CI 95至99)。
  • 队列2的生存率:以任何原因翻修为终点为88%(95%CI 79至97),以无菌性松动为终点为100%。
  • 队列3的生存率:以任何原因翻修为终点为95%(95%CI 91至99),以无菌性松动为终点为100%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this study was to compare the survivorship and radiographic outcomes at ten-year follow-up of three prospective consecutive series of patients each of which received a different design of cementless femoral components for total hip arthroplasty (THA). PATIENTS AND METHODS: In Cohort 1, 91 consecutive patients (100 hips) underwent THA with a cementless porous-coated anatomic femoral stem (PCA) between October 1983 and January 1986. In Cohort 2, 86 consecutive patients (100 hips) underwent THA with an extensively porous-coated cementless femoral stem (Prodigy) between June 1994 and October 1997. In Cohort 3, 88 consecutive patients (100 hips) underwent THA with a proximally porous-coated triple-tapered cementless stem (Summit) between April 2002 and October 2003. All three groups underwent prospective clinical and radiographic evaluation. RESULTS: Kaplan-Meier survivorship analysis of Cohort 1 was 91% (95% confidence interval (CI) 88 to 94) with an endpoint of revision for any reason and 97% (95% CI 95 to 99) with aseptic loosening as the endpoint. Survivorship of Cohort 2 was 88% (95% CI 79 to 97) for revision for any reason and 100% for aseptic loosening. Survivorship of Cohort 3 was 95% (95% CI 91 to 99) for revision for any reason and 100% with aseptic loosening as the endpoint. CONCLUSION: With revision for aseptic loosening of the femoral component as the endpoint, the three femoral components with different design philosophies demonstrated excellent survivorship, ranging from 97% to 100% at ten years. Cite this article: Bone Joint J 2017;99-B(1 Supple A):14-17.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Carlson SW, Liu SS, Callaghan JJ, et al. Not all cementless femoral stems are created equal but the results may be comparable. Bone Joint J. 2017. PMID: 28042113. doi:10.1302/0301-620X.99B1.BJJ-2016-0269.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。